Pacira Reaches IP Deal Allowing Generic Painkiller In 2030

By Adam Lidgett · April 8, 2025, 6:21 PM EDT

Pacira BioSciences has agreed to settle a series of patent infringement lawsuits against Fresenius Kabi and other pharmaceutical companies over Pacira's drug Exparel, a long-acting injectable for managing postsurgical pain....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

PACIRA PHARMACEUTICALS, INC. et al v. EVENUS PHARMACEUTICALS LABORATORIES INC. et al

Case Number

2:21-cv-19829

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

November 08, 2021